PetMed Express
PETS
51 hedge funds and large institutions have $22.2M invested in PetMed Express in 2025 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 17 closing their positions.
90% more call options, than puts
Call options by funds: $742K | Put options by funds: $390K
26% more capital invested
Capital invested by funds: $17.6M → $22.2M (+$4.61M)
0% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 15
1.24% less ownership
Funds ownership: 33.81% → 32.56% (-1.2%)
14% less funds holding
Funds holding: 59 → 51 (-8)
41% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 17
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$611K |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$365K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$195K |
| 4 |
RC
Rangeley Capital
New Canaan,
Connecticut
|
+$188K |
| 5 |
UB
UMB Bank
Kansas City,
Missouri
|
+$151K |
Top Sellers
PETS Hedge Fund Activity: Q4 2025 in Review
51 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in PetMed Express (PETS) for Q4 2025, worth a combined $22.2M — up 26% from $17.6M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of PETS and 10 opened new positions — a net loss of 7 holders — while 15 trimmed existing stakes and 15 added.
The largest buyer was UBS Group, adding an estimated $611K. The largest seller was Oaktop Capital Management II, exiting entirely with an estimated $1.09M sold.
- 51 institutional investors held PetMed Express (PETS) as of Q4 2025, down from 59 in Q3 2025.
- Funds reported $22.2M of PetMed Express stock for Q4 2025, up 26% quarter-over-quarter.
- 10 funds opened new PetMed Express positions in Q4 2025 and 17 closed out, a net change of -7 holders.
- The largest PetMed Express buyer in Q4 2025 was UBS Group, an estimated $611K added.
- The largest PetMed Express seller in Q4 2025 was Oaktop Capital Management II, an estimated $1.09M sold.
Based on aggregated 13F filings for Q4 2025.